DRUG vs. ^GSPC
Compare and contrast key facts about Bright Minds Biosciences Inc (DRUG) and S&P 500 (^GSPC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DRUG or ^GSPC.
Correlation
The correlation between DRUG and ^GSPC is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DRUG vs. ^GSPC - Performance Comparison
Loading data...
Key characteristics
DRUG:
2.12
^GSPC:
0.64
DRUG:
26.07
^GSPC:
1.09
DRUG:
4.14
^GSPC:
1.16
DRUG:
30.55
^GSPC:
0.72
DRUG:
108.46
^GSPC:
2.74
DRUG:
27.51%
^GSPC:
4.95%
DRUG:
1,461.49%
^GSPC:
19.62%
DRUG:
-97.67%
^GSPC:
-56.78%
DRUG:
-40.83%
^GSPC:
-3.02%
Returns By Period
In the year-to-date period, DRUG achieves a -8.38% return, which is significantly lower than ^GSPC's 1.30% return.
DRUG
-8.38%
3.09%
-16.69%
3,013.21%
N/A
N/A
^GSPC
1.30%
12.94%
1.49%
12.48%
15.82%
10.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DRUG vs. ^GSPC — Risk-Adjusted Performance Rank
DRUG
^GSPC
DRUG vs. ^GSPC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bright Minds Biosciences Inc (DRUG) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Drawdowns
DRUG vs. ^GSPC - Drawdown Comparison
The maximum DRUG drawdown since its inception was -97.67%, which is greater than ^GSPC's maximum drawdown of -56.78%. Use the drawdown chart below to compare losses from any high point for DRUG and ^GSPC. For additional features, visit the drawdowns tool.
Loading data...
Volatility
DRUG vs. ^GSPC - Volatility Comparison
Bright Minds Biosciences Inc (DRUG) has a higher volatility of 15.83% compared to S&P 500 (^GSPC) at 5.42%. This indicates that DRUG's price experiences larger fluctuations and is considered to be riskier than ^GSPC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...